Wikipedia:Vaccine safety/Listeria
This page contains automatic lists generated by Listeriabot. Italisized item names indicate that the article of that name does not exist on Wikipedia. For the list of vaccine related journal articles, please go to this page.
Vaccines
[edit]This list is automatically generated from data in Wikidata and is periodically updated by Listeriabot.
Edits made within the list area will be removed on the next update!
| Article | description | vaccine_for | subclass_of |
|---|---|---|---|
| vaccine type | metaclass; a type of substance with immunizing properties | type | |
| Hepatitis B vaccine | vaccine against Hepatitis B | hepatitis B | viral hepatitis vaccines vaccine |
| Hib vaccine | vaccine | Haemophilus influenzae | Haemophilus vaccines conjugate vaccine |
| influenza vaccine | vaccine against influenza | influenza | viral vaccines |
| DNA vaccine | novel type of vaccine | vaccine medication biopharmaceutical | |
| hexavalent vaccine | single vaccine protecting against six individual diseases | combined vaccine | |
| BCG vaccine | vaccine primarily used against tuberculosis | tuberculosis | tuberculosis vaccines heterologous vaccine |
| 2009 flu pandemic vaccine | vaccine to protect against 2009 H1N1 pandemic influenza | pandemic H1N1/09 virus | vaccine |
| HPV vaccine | class of vaccines against human papillomavirus | anogenital venereal wart human papillomavirus infection |
vaccine |
| MMR vaccine | any of several combined vaccines against measles, mumps, and rubella | measles rubella mumps |
attenuated vaccine combined vaccine |
| DPT vaccine | vaccine against diphtheria, pertussis, and tetanus | diphtheria tetanus pertussis |
combined vaccine |
| toxoid | special dead vaccine | inactivated vaccine | |
| smallpox vaccine | first successful vaccine to be developed | smallpox | attenuated vaccine viral vaccines |
| marker vaccine | vaccine which allows for immunological differentiation (or segregation) of infected from vaccinated animals | vaccine | |
| Remune | vaccine | ||
| Pandemrix | flu vaccine | influenza vaccine | |
| virus-like particle | virion that lacks nucleic acid | particle vaccine | |
| HIV vaccine | in-progress vaccinations that may prevent or treat HIV infections | human immunodeficiency virus infectious disease | viral vaccines |
| polio vaccine | vaccine to prevent poliomyelitis | poliomyelitis | vaccine |
| attenuated vaccine | vaccine that uses a weakened (or attenuated) form of the germ that causes a disease | vaccine beneficial organism | |
| cholera vaccine | vaccine that is effective at preventing cholera | cholera | bacterial vaccine |
| live attenuated influenza vaccine | vaccine that is sprayed into the nose to help protect against influenza | influenza vaccine attenuated vaccine | |
| pneumococcal polysaccharide vaccine | pneumococcal vaccine | Streptococcus pneumoniae | pneumococcal vaccine |
| vaccine against diphtheria, tetanus, and poliomyelitis | diphtheria tetanus poliomyelitis |
combined vaccine | |
| cancer vaccine | vaccine that either treats existing cancer or prevents development of cancer | cancer | vaccine |
| Cervarix | HPV vaccine | HPV vaccine | |
| Gardasil | HPV vaccine | HPV vaccine | |
| varicella vaccine | vaccine to prevent chickenpox | chickenpox Human herpesvirus 3 herpes zoster |
Herpesvirus vaccines attenuated vaccine |
| Schistosomiasis vaccine | vaccine against Schistosomiasis | schistosomiasis | vaccine |
| Sabin vaccine | live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio | polio vaccine attenuated vaccine | |
| SAV001 | HIV vaccine | ||
| Ebola vaccine | vaccine to prevent Ebola | Ebola hemorrhagic fever | viral vaccines |
| hepatitis A vaccine | vaccine to prevent Hepatitis A | hepatitis A | viral hepatitis vaccines |
| inactivated vaccine | vaccines that uses the killed version of the germ that causes a disease | vaccine | |
| SPf66 | malaria vaccine | malaria | vaccine |
| rabies vaccine | group of vaccines against infection of humans and animals with the rabies virus | rabies rabies virus |
vaccine |
| anthrax vaccine | vaccine | ANTRAX | bacterial vaccine |
| Japanese encephalitis vaccine | any of several vaccines against Japanese encephalitis | Japanese encephalitis | vaccine |
| plague vaccine | vaccine used against Yersinia pestis | plague Yersinia pestis |
bacterial vaccine |
| Brucellosis vaccine | vaccine for cattle, sheep and goats used against brucellosis | brucellosis | vaccine |
| diphtheria vaccine | vaccine against Corynebacterium diphtheriae, the bacterium that causes diphtheria | diphtheria | bacterial vaccine |
| Vaxigrip | Influenza Vaccine | influenza vaccine | |
| Influvac | Influenza vaccine | influenza vaccine subunit vaccine | |
| rotavirus vaccine | type of vaccine | Rotavirus diarrhea |
viral vaccines |
| 72F fusion protein | candidate tuberculosis vaccine | tuberculosis vaccines vaccine | |
| Avicine | vaccine | cancer vaccine | |
| adenovirus vaccine | vaccine against adenovirus | Adenoviridae | viral vaccines |
| anti-idiotypic vaccine | vaccine | vaccine | |
| Antigen-presenting cell vaccine | vaccine | ||
| CYT006-AngQb | vaccine | vaccine | |
| Calf lymph | vaccine | ||
| caries vaccine | vaccine to prevent and protect against tooth decay | dental caries | vaccine |
| CimaVax-EGF | lung cancer vaccine developed in Cuba | non-small-cell lung carcinoma | cancer vaccine |
| conjugate vaccine | type of vaccine | vaccine subunit vaccine | |
| Cytomegalovirus vaccine | vaccine to prevent cytomegalovirus (CMV) infection | human betaherpesvirus 5 | Herpesvirus vaccines |
| Dryvax | vaccine | ||
| Epstein–Barr vaccine | proposed vaccine against Epstein–Barr virus | Epstein–Barr virus infection | Herpesvirus vaccines |
| Gp100:209-217(210M) | peptide cancer vaccine | cancer vaccine | |
| H5N1 vaccine | influenza vaccine | influenza A virus subtype H5N1 | influenza vaccine |
| Hepacivac | European Initiative to Create Hepatitis C Vaccine | vaccine | |
| Hepatyrix | vaccine | ||
| heterologous vaccine | vaccine | ||
| Historical annual reformulations of the influenza vaccine | influenza vaccine | ||
| tetanus vaccine | vaccines used to prevent tetanus | tetanus | vaccine |
| hookworm vaccine | vaccine against hookworm | hookworm | vaccine |
| HybriCell | vaccine | ||
| MMRV vaccine | combination vaccine against measles, mumps, rubella, and varicella viruses | measles mumps rubella chickenpox |
combined vaccine |
| MVA85A | mva | tuberculosis vaccines vaccine | |
| MVA-B | HIV vaccine | ||
| malaria vaccine | vaccine that is used to prevent malaria | malaria | protozoan vaccines |
| measles vaccine | vaccine used against the disease measles | measles | vaccine |
| MenAfriVac | vaccine developed for use in sub-Saharan Africa | meningococcal vaccine | |
| meningococcal vaccine | vaccines used to prevent infection by Neisseria meningitidis | meningitis meningococcal disease |
bacterial vaccine |
| modified vaccinia Ankara | attenuated vaccine of a poxvirus | Poxviridae | vaccine |
| mumps vaccine | vaccine which prevents mumps | mumps | viral vaccines |
| Neurovax | vaccine brand | multiple sclerosis | vaccine |
| Neuvenge | therapeutic cancer vaccine in development | cancer vaccine | |
| NmVac4-A/C/Y/W-135 | vaccine against bacterial meningitis | vaccine | |
| Optaflu | influenza vaccine | ||
| Oral vaccination against rabies | rabies vaccine | ||
| peptide vaccine | peptide which serves to immunize an organism against a pathogen | vaccine | |
| pertussis vaccine | vaccine protecting against whooping cough | pertussis | bacterial vaccine |
| plant expressed vaccine | vaccine | ||
| pneumococcal conjugate vaccine | pneumococcal vaccine and a conjugate vaccine | Streptococcus pneumoniae | pneumococcal vaccine |
| RBCG30 | prospective tuberculosis vaccine | tuberculosis vaccines vaccine | |
| RTS,S | malaria vaccine | malaria | protein subunit vaccine malaria vaccine |
| rubella vaccine | vaccine used to prevent rubella | rubella | vaccine |
| SCIB1 | vaccine | ||
| synthetic vaccine | synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques | vaccine | |
| TA-NIC | vaccine in development for nicotine addiction | vaccine | |
| TA-CD | vaccine used in treatment of addiction | vaccine | |
| Tcelna | vaccine | ||
| tick-borne encephalitis vaccine | preventive medicine | tick-borne encephalitis | viral vaccines |
| TroVax | vaccine candidate cancer vaccine | ||
| trypanosomiasis vaccine | vaccine against trypanosomiasis | trypanosomiasis | vaccine |
| tuberculosis vaccines | vaccines to prevent tuberculosis | tuberculosis | bacterial vaccine |
| tumor antigen vaccine | vaccine | ||
| Ty21a | typhoid vaccine | typhoid vaccine | |
| typhoid vaccine | vaccines that prevent typhoid fever | typhoid fever | typhoid-paratyphoid vaccines |
| typhus vaccine | vaccines developed to protect against typhus | typhus | rickettsial vaccine |
| Vi capsular polysaccharide vaccine | vaccine for the prevention of typhoid | typhoid fever | typhoid vaccine |
| yellow fever vaccine | vaccine that protects against yellow fever | yellow fever | viral vaccines |
| herpes zoster vaccine | any vaccine to prevent shingles | herpes zoster | Herpesvirus vaccines |
| Immunization registry | immunization information system | vaccine immunization | |
| NicVAX | experimental nicotine dependency vaccine | conjugate vaccine vaccine | |
| Hasumi vaccine | cancer vaccine | ||
| recombinant vaccine | vaccine produced through recombinant DNA technology | vaccine | |
| subunit vaccine | vaccine consisting of one or more antigens that stimulate a strong immune response | vaccine | |
| pneumococcal vaccine | vaccine to prevent infection by the bacterium Stretococcus pneumoniae | pneumococcal infection | streptococcal vaccines |
| AIDSVAX | experimental vaccine developed by Genentech against Human Immunodeficiency Virus (HIV) | vaccine | |
| Anthrax Vaccine Adsorbed | vaccine | anthrax vaccine | |
| Mumpsvax | mumps vaccine | ||
| cell-based vaccine | vaccine | ||
| Live vector vaccine | vaccine | ||
| Twinrix | vaccine against hepatitis virus A and B | hepatitis A hepatitis B |
hepatitis A vaccine Hepatitis B vaccine inactivated vaccine |
| PneumoADIP | vaccine | ||
| Edible algae vaccine | vaccination strategy under preliminary research to combine a genetically engineered sub-unit vaccine and an immunologic adjuvant into Chlamydomonas reinhardtii microalgae | vaccine | |
| Hantavirus vaccine | vaccine that protects humans against hantavirus infections | Hantavirus | vaccine |
| MeNZB | meningococcal vaccine | meningococcal vaccine | |
| HspE7 | investigational HPV vaccine | vaccine | |
| hepatitis C vaccine | Possible vaccine and research into it | hepatitis C | vaccine |
| Vaccin diphtérique, tétanique, coquelucheux, poliomyélitique et de l'Haemophilus type b | combined vaccine | ||
| DTaP-IPV vaccine | Vaccine against diphtheria, tetanus, whooping cough and polio | diphtheria poliomyelitis pertussis tetanus |
combined vaccine |
| PFSPZ vaccine | malaria vaccine | vaccine candidate malaria vaccine | |
| VSV-EBOV | experimental vaccine against Ebola virus disease | vaccine candidate Ebola vaccine | |
| cAd3-ZEBOV | experimental vaccine for two ebolaviruses | Ebolavirus Ebola hemorrhagic fever |
Ebola vaccine |
| MVA-BN smallpox vaccine | smallpox vaccine | smallpox | smallpox vaccine |
| pentavalent vaccine | combination vaccine with five individual vaccines conjugated into one, intended to actively protect people from multiple diseases. | combined vaccine | |
| dengue vaccine | vaccine used to prevent dengue fever in humans | dengue fever | viral vaccines |
| Quinvaxem | combination vaccine (tradename) | DTwP-HepB-Hib vaccine | |
| vacunes de deleció | vaccine | ||
| Zika fever vaccine | vaccine in development | Zika fever | vaccine |
| GLS-5700 | potential Zika vaccine | DNA vaccine | |
| Dengvaxia | Dengue vaccine | dengue vaccine | |
| Prostvac | prostate cancer vaccine | vaccine candidate | |
| T-cell vaccine | vaccine designed to induce protective T-cells | vaccine | |
| rindopepimut | chemical compound | vaccine | |
| universal flu vaccine | vaccine that prevents infection from all strains of the flu | vaccine | |
| vaccine candidate | pharmaceutical preparation being tested for use in preventing infections | vaccine | |
| Ovandrotone albumin | immunogen and vaccine against androstenedione | vaccine | |
| Androvax | vaccine | vaccine | |
| AGS-v | vaccine candidate | vaccine candidate | |
| hepatitis b virus hbsag surface protein antigen | pharmaceutical drug | Hepatitis B vaccine | |
| varicella-zoster virus strain oka/merck live antigen | pharmaceutical drug | varicella vaccine | |
| Provenge | pharmaceutical product | cancer vaccine | |
| Zostavax | live attenuated vaccine against shingles by Merck | herpes zoster | herpes zoster vaccine attenuated vaccine |
| Shingrix | recombinant subunit vaccine by GSK | herpes zoster | herpes zoster vaccine recombinant vaccine |
| suicidal DNA vaccine | DNA vaccine containing suicidal DNA | DNA vaccine suicide gene | |
| DTaP-IPV-HepB vaccine | Combination vaccine | pentavalent vaccine | |
| DTaP-IPV/Hib vaccine | combination vaccine | pentavalent vaccine | |
| Haemophilus B and hepatitis B vaccine | bivalent vaccine | ||
| bivalent vaccine | combined vaccine | ||
| CHIKV/IRES vaccine candidate | vaccine candidate for chikungunya | vaccine candidate | |
| heptavalent pneumococcal conjugate vaccine | pneumococcal vaccine in which seven pneumococcal serotypes are conjugated individually to a protein complex of Neisseria meningitidis | pneumococcal conjugate vaccine combined vaccine | |
| streptococcal vaccines | vaccines or candidate vaccines used to prevent streptococcal infections | streptococcal infection | bacterial vaccine |
| salmonella vaccines | vaccines or candidate vaccines used to prevent infection with salmonella, including vaccines used to prevent typhoid fever or paratyphoid fever and vaccines used to prevent nontyphoid salmonellosis | Salmonella food poisoning | bacterial vaccine |
| inactivated poliovirus vaccine | suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent poliomyelitis | inactivated vaccine polio vaccine | |
| diphtheria–tetanus vaccine | combined vaccine used to prevent infection with diphtheria and tetanus toxoid, used in place of DTP vaccine when pertussis vaccine is contraindicated | diphtheria tetanus |
combined vaccine |
| Brucella vaccine | bacterial vaccine for the prevention of brucellosis in man and animal | brucellosis | bacterial vaccine |
| staphylococcal vaccine | staphylococcus vaccine | staphylococcal infection | bacterial vaccine |
| virus-like particle vaccine | vaccine using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins | vaccine | |
| Marek Disease vaccines | vaccines or candidate vaccines used to prevent Marek Disease, an avian disease caused by a herpesvirus | Marek's disease | vaccine |
| protozoan vaccines | suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease | parasitic protozoa infectious disease | vaccine |
| Herpesvirus vaccines | vaccines or candidate vaccines used to prevent infection by any virus from the family Herpesviridae | Herpesviridae infectious disease | viral vaccines |
| parainfluenza vaccines | vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals | human parainfluenza | viral vaccines |
| Leishmaniasis vaccines | vaccines or candidate vaccines used to prevent infection with Leishmania | leishmaniasis | protozoan vaccines |
| fungal vaccines | suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease | fungal infectious disease | vaccine |
| diphtheria–tetanus–acellular pertussis vaccine | combination vaccine containing diphtheria, tetanus, and acellular pertussis toxoids | diphtheria tetanus |
DPT vaccine |
| West Nile Virus vaccine | vaccine or candidate vaccine used to prevent infection with West Nile Virus | West Nile fever | viral vaccines |
| acellular vaccines | vaccines produced by using only the antigenic part of the disease causing organism | vaccine | |
| Escherichia coli vaccines | vaccines or candidate vaccines used for Escherichia coli infections | Escherichia coli infectious disease | bacterial vaccine |
| viral hepatitis vaccines | vaccine raised against any virus or viral derivative that causes hepatitis | viral hepatitis | viral vaccines |
| viral vaccines | suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease | viral infectious disease | vaccine |
| Shigella vaccines | vaccines or candidate vaccines used to prevent bacillary dysentery caused by species of Shigella | shigellosis | bacterial vaccine |
| typhoid-paratyphoid vaccines | vaccines used to prevent typhoid fever and paratyphoid fever | salmonella vaccines | |
| respiratory syncytial virus vaccines | vaccines or candidate vaccines used to prevent infection with respiratory syncytial virus | respiratory syncytial virus infectious disease | viral vaccines |
| Haemophilus vaccines | vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection | Haemophilus influenzae infectious disease | bacterial vaccine |
| Lyme Disease vaccines | vaccines or candidate vaccines used to prevent Lyme Disease | Lyme disease | bacterial vaccine |
| pseudorabies vaccines | vaccines or candidate vaccines used to prevent pseudorabies (Aujeszky's disease), a herpesvirus of swine and other animals | pseudorabies | vaccine |
| live unattenuated vaccines | vaccines prepared from microorganisms without their virulence altered | vaccine | |
| SAIDS vaccines | vaccines or candidate vaccines designed to prevent simian acquired immunodeficiency syndrome | simian acquired immunodeficiency syndrome | viral vaccines |
| bacterial vaccine | suspension of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease | bacterial infectious disease | vaccine |
| contraceptive vaccines | vaccines or candidate vaccines used to prevent conception | vaccine | |
| rickettsial vaccine | vaccine for the prevention of diseases caused by species of Rickettsia | rickettsiosis | bacterial vaccine |
| combined vaccine | two or more vaccines in a single dosage form | vaccine | |
| Pseudomonas vaccines | Vaccines or candidate vaccines used to prevent or treat Pseudomonas infections | Pseudomonas infection | bacterial vaccine |
| virosome vaccines | vaccines using virosomes as antigen delivery system | vaccine | |
| Herpes Simplex Virus vaccines | vaccines or candidate vaccines used to prevent infection with viruses from the genus Simplexvirus; includes vaccines for HSV-1 and HSV-2 | Herpes simplex virus type 1 | Herpesvirus vaccines |
| Alzheimer vaccines | vaccines or candidate vaccines used to prevent or treat Alzheimer's disease | Alzheimer's disease | vaccine |
| Agrippal S1 | influenza vaccine | ||
| スギ花粉米 | rice-based edible vaccine | Edible vaccines | |
| Priorix | MMR vaccine brand | measles mumps rubella |
MMR vaccine |
| Edible vaccines | food that aids immunity against a disease | vaccine | |
| Stamaril | yellow fever vaccine brand | yellow fever vaccine attenuated vaccine | |
| YF-Vax | yellow fever vaccine brand | yellow fever vaccine attenuated vaccine | |
| RotaTeq | vaccine against rotavirus | rotavirus vaccine attenuated vaccine | |
| Rotarix | vaccine against rotavirus | rotavirus vaccine attenuated vaccine | |
| Imovax | vaccine against rabies for humans | rabies vaccine inactivated vaccine | |
| Verorab | vaccine against rabies for humans | rabies vaccine inactivated vaccine | |
| RNA vaccine | vaccine that transfects synthetic RNA to reprogram cells to make foreign protein that stimulates an adaptive immune response | medication biopharmaceutical nucleic acid-based vaccine RNA therapeutics | |
| COVID-19 vaccine | vaccine against SARS-CoV-2 coronavirus | COVID-19 | viral vaccines |
| PR1 leukemia peptide vaccine | type of cancer vaccine | vaccine | |
| INO-4800 | experimental vaccine against COVID-19 | COVID-19 | vaccine candidate DNA vaccine |
| adenovirus-based vaccine | a vaccine based on a non-replicating viral vector | viral vector vaccine | |
| protein subunit vaccine | vaccine containing recombinant proteins derived from parts of the targeted pathogen | vaccine | |
| ZyCoV-D | DNA vaccine against COVID-19 | COVID-19 | DNA vaccine vaccine candidate |
| GX-19 | candidate vaccine against COVID-19 | COVID-19 | vaccine candidate DNA vaccine |
| Institute of Medical Biology COVID-19 vaccine candidate | candidate vaccine against COVID-19 | COVID-19 | inactivated vaccine vaccine candidate |
| SCB-2019 | candidate vaccine against COVID-19 | COVID-19 | protein subunit vaccine vaccine candidate |
| LNP-nCoVsaRNA | candidate vaccine against COVID-19 | COVID-19 | RNA vaccine vaccine candidate |
| Arcov | candidate vaccine against COVID-19 | COVID-19 | RNA vaccine vaccine candidate |
| Medicago Inc. COVID-19 vaccine candidate | candidate vaccine against COVID-19 | COVID-19 | virus-like particle vaccine vaccine candidate vaccine |
| Autogenous vaccines | bacterial vaccine prepared from non-pathogenic, autologous bacteria of human origin | vaccine | |
| AG0301-COVID19 | experimental COVID-19 vaccine | COVID-19 | DNA vaccine vaccine candidate |
| Finlay-FR-1 | experimental COVID-19 vaccine | COVID-19 | protein subunit vaccine vaccine candidate |
| University of Queensland COVID-19 vaccine candidate | experimental COVID-19 vaccine | COVID-19 | protein subunit vaccine vaccine candidate |
| Lunar-COV19 | experimental COVID-19 vaccine | COVID-19 | RNA vaccine vaccine candidate |
| GamEvac-Combi | heterologous VSV- and Ad5-vectored Ebola vaccine | Ebola vaccine | |
| GRAd-COV2 | experimental COVID-19 vaccine | COVID-19 | adenovirus-based vaccine vaccine candidate |
| QazCovid-in | experimental COVID-19 vaccine | COVID-19 | inactivated vaccine vaccine candidate |
| West China Hospital COVID-19 vaccine candidate | experimental COVID-19 vaccine | protein subunit vaccine vaccine candidate | |
| V591 | experimental COVID-19 vaccine | COVID-19 | replicating viral vector vaccine vaccine candidate |
| replicating viral vector vaccine | active artificial (harmless) virus containing target antigen | viral vector vaccine | |
| Совигрипп | influenza | influenza vaccine | |
| OC-007 | vaccine | ||
| genetically modified vaccine | class of vaccine | attenuated vaccine | |
| RegaVax | COVID-19 yellow fever |
vaccine | |
| V451 | experimental vaccine targeting SARS-CoV-2 | vaccine | |
| INFANRIX HEXA | hexavalent vaccine by GlaxoSmithKline | hexavalent vaccine | |
| vector-based vaccine | type of vaccine | vaccine | |
| therapeutic vaccine | vaccine or vaccine candidate for use in treatment of a disease | vaccine | |
| prophylactic vaccine | vaccine or vaccine candidate for use in preventing disease | vaccine | |
| CoviVac | vaccine rusa | COVID-19 | vaccine |
| People's Vaccine | concept in vaccine equity | vaccine | |
| viral vector vaccine | type of vaccine | vaccine | |
| Mambisa | vaccine against COVID-19 | COVID-19 | COVID-19 vaccine subunit vaccine |
| FAKHRAVAC | vaccine candidate against COVID-19 | COVID-19 | inactivated vaccine |
| Universal coronavirus vaccine | vaccine that prevents infection from all strains of coronaviruses | vaccine | |
| monkeypox vaccine | vaccine against the monkeypox virus | mpox | |
| Q fever vaccine | vaccine for preventing Q fever infection in humans | Q fever | bacterial vaccine |
| ACAM2000 smallpox vaccine | smallpox vaccine | smallpox vaccine | |
| DTwP-HepB-Hib vaccine | combination vaccine | pentavalent vaccine | |
| R21/Matrix-M | malaria vaccine | malaria | malaria vaccine protein subunit vaccine |
| HPV治療ワクチン | |||
| Gardasil 9 | HPV vaccine | human papillomavirus infection | |
| falimarev | cancer vaccine made with a form of a chicken virus that does not cause disease in humans | ||
| Prevnar 13 | |||
| mRNA-1283 | vaccine candidate against COVID-19 | COVID-19 | |
| mRNA-1083 | combined vaccine candidate against influenza and Covid | COVID-19 influenza |
|
| BNT162b5 | vaccine against SARS-CoV-2 | ||
| mRNA-1273.214 vaccine | mRNA vaccine for COVID-19 | COVID-19 | |
| vaccinal liquid in the first COVID-19 shot given to Sarah Lindsay | the actual substance that was injected into Sarah Lindsay's body in the moment of vaccination | ||
| West China Hospital COVID-19 vaccine | vaccine candidate against COVID-19 | ||
| Bimervax | |||
| Crohns MAP Vaccine | Crohn's disease |
End of auto-generated list.
Journals on vaccines
[edit]This list is automatically generated from data in Wikidata and is periodically updated by Listeriabot.
Edits made within the list area will be removed on the next update!
End of auto-generated list.
Vaccine candidates
[edit]This list is automatically generated from data in Wikidata and is periodically updated by Listeriabot.
Edits made within the list area will be removed on the next update!
| Article | description |
|---|---|
| mRNA-1283 | vaccine candidate against COVID-19 |
| mRNA-1083 | combined vaccine candidate against influenza and Covid |
End of auto-generated list.
Institutes in India
[edit]This list is automatically generated from data in Wikidata and is periodically updated by Listeriabot.
Edits made within the list area will be removed on the next update!
End of auto-generated list.